# Photocure clinical trials: 23 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Photocure as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Photocure: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/photocure

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 27, 2025 | NCT07144319 | Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy | Photocure | Observational | Recruiting | Bladder Cancer, Non-muscle Invasive Bladder Cancer | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144319) |
| October 31, 2022 | NCT05600322 | Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer | Photocure | Phase 3 | Completed | Bladder Cancer | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05600322) |
| January 21, 2016 | NCT02660645 | Blue Light Cystoscopy With Cysview® Registry | Photocure | Observational | Recruiting | Bladder Cancer | 4,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02660645) |
| September 25, 2015 | NCT02560584 | A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting | Photocure | Phase 3 | Completed | Bladder Cancer | 304 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02560584) |
| March 12, 2012 | NCT01551407 | Detection of Bladder Tumors After 30 Min Instillation of Hexvix | Photocure | Phase 2 | Terminated | Bladder Cancer | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01551407) |
| May 4, 2011 | NCT01347879 | A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients... | Photocure | Phase 2 | Completed | Acne Vulgaris | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01347879) |
| April 29, 2011 | NCT01344902 | An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the... | Photocure | Phase 1/2 | Terminated | Colon Cancer | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01344902) |
| February 25, 2011 | NCT01303991 | Hexvix Photodynamic Therapy in Patients With Bladder Cancer | Photocure | Phase 1 | Completed | Intermediate or High-risk Bladder Cancer | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01303991) |
| December 8, 2010 | NCT01256424 | Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia | Photocure | Phase 2 | Completed | Cervical Intraepithelial Neoplasia | 262 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01256424) |
| July 20, 2010 | NCT01166230 | Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB | Photocure | Observational | Completed | Bladder Cancer | 551 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01166230) |
| July 12, 2010 | NCT01160848 | Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients | Photocure | Phase 2 | Completed | Acne Vulgaris | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01160848) |
| January 15, 2010 | NCT01050309 | An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After... | Photocure | Phase 1 | Completed | Pharmacokinetics | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01050309) |
| July 7, 2009 | NCT00933543 | Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT) | Photocure | Phase 2 | Completed | Acne Vulgaris | 107 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00933543) |
| January 30, 2009 | NCT00833183 | Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne | Photocure | Phase 2 | Completed | Acne | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00833183) |
| July 3, 2008 | NCT00708942 | Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 | Photocure | Phase 2 | Terminated | Cervical Intraepithelial Neoplasia | 83 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00708942) |
| May 7, 2008 | NCT00673933 | Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris | Photocure | Phase 2 | Completed | Acne Vulgaris | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00673933) |
| January 15, 2008 | NCT00594425 | Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne | Photocure | Phase 2 | Completed | Acne Vulgaris | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00594425) |
| July 4, 2007 | NCT00496171 | Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers | Photocure | Observational | Terminated | Healthy | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00496171) |
| December 19, 2006 | NCT00412971 | A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer | Photocure | Phase 3 | Completed | Bladder Cancer | 233 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00412971) |
| August 29, 2006 | NCT00369018 | A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. | Photocure | Phase 1/2 | Completed | Cervical Dysplasia | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00369018) |
| February 2, 2006 | NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | Photocure | Phase 1/2 | Completed | Colorectal Cancer | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00285701) |
| October 5, 2005 | NCT00233402 | Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy | Photocure | Phase 3 | Completed | Bladder Cancer | 789 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00233402) |
| January 27, 2003 | NCT00052637 | Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer | Photocure | Phase 3 | Completed | Bladder Cancer | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00052637) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 2 |
| Phase 1/2 | 3 |
| Phase 2 | 9 |
| Phase 3 | 5 |
| Observational | 4 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Terminated | 4 |
| Recruiting | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Urinary Bladder Neoplasms | 9 |
| Acne Vulgaris | 6 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Uterine Cervical Dysplasia | 3 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Vegetarian restaurants in the United States](https://specstream.ai/data/businesses/vegetarian-restaurants/united-states)
- [Allergy and immunology practices in the United States](https://specstream.ai/data/businesses/allergy-and-immunology-practices/united-states)
- [B2B radio and television commercials companies in the United States](https://specstream.ai/data/businesses/b2b-radio-and-television-commercials-companies/united-states)
- [Business schools in the United States](https://specstream.ai/data/businesses/business-schools/united-states)
- [Corporate gift suppliers in the United States](https://specstream.ai/data/businesses/corporate-gift-suppliers/united-states)
- [Electricians in the United States](https://specstream.ai/data/businesses/electricians/united-states)
